Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CytRx files to move Lou Gehrig’s drug into phase II
CytRx has assembled a team of renowned neurologists throughout the US to conduct the planned phase II clinical trial. The company announced in May that arimoclomol was granted
CytRx has assembled a team of renowned neurologists throughout the US to conduct the planned phase II clinical trial. The company announced in May that arimoclomol was granted
The initial phase I/II, open-label, dose-escalation trial of GRN163L will be conducted in patients with advanced chronic lymphocytic leukemia (CLL). The study is designed to demonstrate the safety
Cellzome is currently developing a series of small-molecule gamma secretase modulators (GSMs) for the treatment of Alzheimer’s disease. These compounds are directed towards preventing the formation of toxic
The collective data from phase II studies, presented at the centenary meeting of the American Thoracic Society (ATS), show indacaterol (QAB149) provides bronchodilation for up to 24 hours,
Alvesco (ciclesonide) is an inhaled corticosteroid with novel release and distribution properties. Inhaled corticosteroids, considered to be the foundation of asthma treatment, work by reducing inflammation – the
IBM’s Healthcare and Life Sciences unit said it has developed a framework, called Proof of Concept (PoC), that demonstrates how the Food and Drug Administration’s (FDA) Science of
The obesity study examined the association between body mass index and prostate cancer in 787 men undergoing biopsy due to an elevated tumor marker in the blood or
The five-year Alzheimer’s Disease Research Center grant, which will support more than 30 University of California, Irvine (UCI) faculty investigators, renews an expiring $6 million grant from the
Market forces alone are not sufficient to produce new drugs needed for children with cancer, according to the Institute of Medicine (IOM) report, which recommends forming new partnerships
Visceral leishmaniasis (VL), also known as kala azar (“black fever”), is a fatal disease transmitted by sand flies, which spread leishmania parasites that attack internal organs. The US